Mike Ferguson

Mike obtained a PhD in Biochemistry in London and was a post-doc at the Rockefeller University and Oxford University before moving to the University of Dundee. Mike was appointed the first Regius Professor of Life Sciences in 2013. He is known for his work on the structure and biosynthesis of parasite surface molecules and for solving the first structures of glycosylphosphatidylinositol (GPI) membrane anchors, which play important roles throughout eukaryotic biology. He believes in working across disciplines and in translational research. He helped establish the Drug Discovery Unit and the Proteomics Facility at the University of Dundee. 

Mike is a fellow of the Royal Societies of London and Edinburgh and of the Academy of Medical Sciences and a member of EMBO. He was knighted in 2019 for services to science. He is also Deputy Chair of the Board of Governors of the Wellcome Trust and a member of the Board of Directors of the Medicines for Malaria Venture (MMV).